O
ESPR

OrbiMed’s Esperion Therapeutics ESPR Stock Holding History

OrbiMed’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29M Buy
10,570,300
+4,604,802
+77% +$14.6M 0.63% 49
2025
Q4 		$22.1M Buy
+5,965,498
New +$19.3M 0.45% 56
2024
Q2 		– Sell
-13,708,731
Closed -$36.7M – 121
2024
Q1 		$36.7M Buy
+13,708,731
New +$33.3M 0.67% 46
2013
Q4 		– Sell
-60,800
Closed -$1.15M – 129
2013
Q3 		$1.15M Buy
+60,800
New +$1.02M 0.02% 124

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return